JNP

Juniper Pharmaceuticals, Inc. Common Stock
JNP

Overview Fund Activity
Delisted

JNP was delisted on the 13th of August, 2018.

Back to rankings

51 hedge funds and large institutions have $42.2M invested in Juniper Pharmaceuticals, Inc. Common Stock in 2015 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 14 increasing their positions, 17 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
51
Holders Change
+7
Holders Change %
+15.91%
% of All Funds
1.43%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
14
Reduced
17
Closed
4
Calls
$1.56M
Puts
$421K
Net Calls
+$1.14M
Net Calls Change
+$904K

Top Buyers

1
Morgan Stanley
1
Morgan Stanley
New York
$3.85M
2
EI
2
EAM Investors
California
$1.72M
3
BA
3
BlackRock Advisors
Delaware
$1.32M
4
TC
4
TFS Capital
Pennsylvania
$1.18M
5
Acadian Asset Management
5
Acadian Asset Management
Massachusetts
$1.07M

Top Sellers

1
GF
1
Gabelli Funds
New York
$530K
2
MERSOM
2
Municipal Employees' Retirement System of Michigan
Michigan
$137K
3
PCM
3
Perritt Capital Management
Illinois
$1.1M
4
CCM
4
Cadence Capital Management
Massachusetts
$1.04M
5
BAMS
5
Bellevue Asset Management (Switzerland)
Switzerland
$589K
Name Holding Trade Value Shares
Change 		Shares
Change %
OAM
51
Oxford Asset Management
United Kingdom
– -$303K -33,107 Closed
Deutsche Bank
52
Deutsche Bank
Germany
– -$74K -8,161 Closed
PCM
53
Prelude Capital Management
New York
– -$3K -300 Closed
Group One Trading
54
Group One Trading
Illinois
– -$2K -203 Closed
1 2
3